Quantum BioPharma Taps Thermo Fisher for Lucid-MS Trial
Quantum BioPharma has signed an agreement with Thermo Fisher's PPD Clinical Research Business to implement its FDA-cleared Phase 2 trial for Lucid-MS in progressive multiple sclerosis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.